Category:C-Class pharmacology articles
 | Administrators: Please do not delete this category as empty! This category may be empty occasionally or even most of the time. |
 FA |  A |  GA | B | C | Start | Stub | FL | List | Category | Disambig | Draft | File | Portal | Project | Redirect | Template | NA | ??? |
| 12 | 0 | 47 | 605 | 1,328 | 4,109 | 7,125 | 1 | 428 | 1,105 | 13 | 26 | 43 | 0 | 23 | 921 | 385 | 16 | 5 |
Pages in category "C-Class pharmacology articles"
The following 200 pages are in this category, out of approximately 1,328 total. This list may not reflect recent changes.
(previous page) (next page)D
- Talk:Discovery and development of integrase inhibitors
- Talk:Discovery and development of neuraminidase inhibitors
- Talk:Discovery and development of nucleoside and nucleotide reverse-transcriptase inhibitors
- Talk:Discovery and development of phosphodiesterase 5 inhibitors
- Talk:Discovery and development of triptans
- Talk:Discovery and development of TRPV1 antagonists
- Talk:Discrimination against drug addicts
- Talk:Disulfiram-alcohol reaction
- Talk:Disulfiram-like drug
- Talk:Diuretic
- Talk:Divinyl ether
- Talk:Doctor of Pharmacy
- Talk:Docusate
- Talk:Donanemab
- Talk:Donepezil
- Talk:Donislecel
- Talk:Dopamine agonist
- Talk:Dopexamine
- Talk:Doping at the Olympic Games
- Talk:Dosulepin
- Talk:Doxifluridine
- Talk:DPT vaccine
- Talk:Drostanolone
- Talk:Drostanolone propionate
- Talk:Drug
- Talk:Drug class
- Talk:Drug delivery to the brain
- Talk:Drug development
- Talk:Drug discovery
- Talk:Drug interaction
- Talk:Drug metabolism
- Talk:Drug policy
- Talk:Drug policy of the United Kingdom
- Talk:Drug resistance
- Talk:Drug utilization review
- Talk:Drug-induced QT prolongation
- Talk:Drugs and Cosmetics Rules, 1945
- Talk:Drugs for acid-related disorders
- Talk:Drugs in pregnancy
- Talk:DTwP-HepB-Hib vaccine
- Talk:Duocarmycin
E
- Talk:Ear drop
- Talk:James Eberwine
- Talk:Ebola vaccine
- Talk:EC508
- Talk:EC586
- Talk:Ecballium
- Talk:Edoxaban
- Talk:Efavirenz
- Talk:Efavirenz/emtricitabine/tenofovir
- Talk:Effect of caffeine on memory
- Talk:Effects of long-term benzodiazepine use
- Talk:Efficacy
- Talk:Efgartigimod alfa
- Talk:Eflornithine
- Talk:Efonidipine
- Talk:Elbasvir/grazoprevir
- Talk:Eldecalcitol
- Talk:Electronic patient-reported outcome
- Talk:Electronic prescribing
- Talk:Elevated plus maze
- Talk:Elexacaftor/tezacaftor/ivacaftor
- Talk:Eli Lilly and Company
- Talk:Elivaldogene autotemcel
- Talk:Elotuzumab
- Talk:Emamectin
- Talk:Emixustat
- Talk:Emodepside
- Talk:Empagliflozin/linagliptin
- Talk:Empagliflozin/metformin
- Talk:Empatica
- Talk:The Emperor's New Drugs
- Talk:Emtricitabine/tenofovir
- Talk:Emulsion
- Talk:Enclomifene
- Talk:Enobosarm
- Talk:Enoxacin
- Talk:Ensitrelvir
- Talk:Entecavir
- Talk:Entheogen
- Talk:Environmental impact of pharmaceuticals and personal care products
- Talk:Environmental persistent pharmaceutical pollutant
- Talk:Eoxin
- Talk:Epcoritamab
- Talk:Epelsiban
- Talk:Eperisone
- Talk:Epigallocatechin gallate
- Talk:Epigenetics of cocaine addiction
- Talk:Epinephrine autoinjector
- Talk:Epirubicin
- Talk:Equianalgesic
- Talk:Erdosteine
- Talk:Ergoline
- Talk:Ergoloid
- Talk:Ertapenem
- Talk:Erythritol
- Talk:Erythrohydrobupropion
- Talk:Erythropoiesis-stimulating agent
- Talk:Esketamine
- Talk:Eslicarbazepine acetate
- Talk:Estazolam
- Talk:Estetrol
- Talk:Estradiol acetate
- Talk:Estradiol benzoate/progesterone
- Talk:Estradiol sulfamate
- Talk:Estrone (medication)
- Talk:Ethinylestradiol sulfonate
- Talk:Ethisterone
- Talk:Ethnopsychopharmacology
- Talk:Ethyl eicosapentaenoic acid
- Talk:Etidronic acid
- Talk:Etizolam
- Talk:Etonogestrel
- Talk:Eucalyptus oil
- Talk:Evergreening
- Talk:Excipient
- Talk:Exemestane
- Talk:Eye drop
F
- Talk:Faculty of Pharmaceutical Medicine
- Talk:Favipiravir
- Talk:Fecal microbiota
- Talk:Federal Food, Drug, and Cosmetic Act of 1938
- Talk:Fenethylline
- Talk:Fenfluramine
- Talk:Fenfluramine/phentermine
- Talk:Wilburn Ferguson
- Talk:Festina affair
- Talk:Fexofenadine
- Talk:Finafloxacin
- Talk:Fine chemical
- Talk:First-in-class medication
- Talk:Fisherman's Friend
- Talk:Fisons
- Talk:Fleroxacin
- Talk:Flow cytometry
- Talk:Fluasterone
- Talk:Fluconazole
- Talk:Fludrocortisone
- Talk:Flumazenil
- Talk:Flumequine
- Talk:Flumezapine
- Talk:Flunitrazepam
- Talk:Fluoride therapy
- Talk:Fluoride toxicity
- Talk:Fluoxymesterone
- Talk:Flurazepam
- Talk:Flurothyl
- Talk:Fluticasone furoate/umeclidinium bromide/vilanterol
- Talk:Folate targeting
- Talk:Food and Drug Administration
- Talk:Food safety
- Talk:Forasartan
- Talk:Forensic toxicology
- Talk:FOSB
- Talk:Fosfestrol
- Talk:Fosfomycin
- Talk:Fostamatinib
- Talk:Frangula purshiana
- Talk:Joseph Fuisz
- Talk:Fulvestrant
G
- Talk:G protein
- Talk:GABAA receptor positive allosteric modulator
- Talk:Gabapentinoid
- Talk:Gabasync
- Talk:Gantacurium chloride
- Talk:Gasotransmitter
- Talk:Gated drug delivery systems
- Talk:Gedeon Richter (company)
- Talk:Gefitinib
- Talk:General anaesthetic
- Talk:Genistein
- Talk:Gentamicin
- Talk:Gestodene
- Talk:Gestonorone caproate
- Talk:Gestrinone
- Talk:Hamid Ghandehari
- Talk:GI cocktail
- Talk:Glutamate transporter
- Talk:Glutamic acid
- Talk:Glutamine
- Talk:Glybuzole
- Talk:Glycerol
- Talk:Glyceryl octyl ascorbic acid
- Talk:Glysobuzole
- Talk:Gold nanoparticles in chemotherapy
- Talk:Gold-containing drugs
- Talk:Dora Goldstein
- Talk:Gonadotropin
- Talk:Gonadotropin-releasing hormone
- Talk:Grapefruit–drug interactions
- Talk:GSK plc
- Talk:GW501516